DB13656InvestigationalSmall molecule
Eberconazole is a broad-spectrum imidazole derivative.
- Mechanism
- Curator reviewed · 2 references
Eberconazole shares a mechanism of action with other antimycotic azoles: It inhibits lanosterol 14a-demethylase, thereby blocking the synthesis of precursors of ergosterols.
- Formula / weight
- C18H14Cl2N2 · 329.22 g/mol (avg)
Resolves to
Clinical / RWD
Structure
InChIKey
MPTJIDOGFUQSQH-UHFFFAOYSA-NSMILESClC1=CC(Cl)=C2C(N3C=CN=C3)C3=CC=CC=C3CCC2=C1Targets
What you can answer from here — as of September 13, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Eberconazole, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account